Breaking Down Zhejiang Hugeleaf Co.,Ltd. Financial Health: Key Insights for Investors

Breaking Down Zhejiang Hugeleaf Co.,Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Agricultural Inputs | SHH

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Zhejiang Hugeleaf Co.,Ltd. presents a compelling yet mixed financial picture for investors: annual revenue reached CN¥1.2 billion for the year ended December 31, 2024-an impressive 23.6% year-over-year rise-with quarterly revenue growth accelerating to 86.4% as of March 31, 2025, while TTM gross profit of CN¥130.36 million yields a 8.5% gross margin versus a Chemicals industry average of 23.8%; the company reported TTM net income of CN¥196.38 million (diluted EPS CN¥0.06) and a net profit margin of 12.99%, set against troubling operating cash flow TTM of CN¥-61.86 million, a MRQ debt-to-equity of 21.31 with total debt of CN¥631.11 million and cash of CN¥779.33 million, a market cap of CN¥8.21 billion, a trailing P/E of 46.00 and EV/EBITDA of 127.56-details that demand a closer read for anyone weighing valuation, liquidity and growth catalysts such as the eco-friendly fabric and biodegradable tea-bag launches that already contributed meaningful revenue and product-sales gains

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) - Revenue Analysis

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) reported total revenue of CN¥1.2 billion for the fiscal year ended December 31, 2024, representing a 23.6% increase versus 2023. The company entered 2025 with accelerating top-line momentum, delivering an 86.4% quarterly revenue growth as of March 31, 2025. Despite strong sales expansion, gross profitability remains compressed: TTM gross profit was CN¥130.36 million, producing a gross margin of 8.5% versus an industry average of 23.8%.
  • Total revenue (FY2024): CN¥1.2 billion (+23.6% YoY)
  • Quarterly revenue growth (Q1 2025 vs Q1 2024): +86.4%
  • Gross profit (TTM): CN¥130.36 million
  • Gross margin (TTM): 8.5% (industry average 23.8%)
  • Revenue per share (TTM): CN¥0.47
  • Quarterly earnings growth: +11% YoY
  • Chemicals industry average earnings change: -3.6% annually (company outpaced)
The 2023 launch of an eco-friendly fabrics line contributed meaningfully to product diversification, generating approximately US$5 million in revenue in its first quarter post-launch. This product-driven uplift helps explain the company's revenue acceleration relative to the broader Chemicals sector, which experienced a 3.6% annual earnings decline while Zhejiang Hugeleaf expanded.
Metric Value Period Comment
Total Revenue CN¥1.2 billion FY2024 +23.6% YoY
Quarterly Revenue Growth +86.4% Q1 2025 YoY Strong sequential momentum
Gross Profit (TTM) CN¥130.36 million TTM Gross margin 8.5%
Industry Gross Margin 23.8% Benchmark Company below industry average
Revenue per Share (TTM) CN¥0.47 TTM Reflects broader revenue gains
Quarterly Earnings Growth +11% Most recent quarter YoY Improved profitability trend
Eco-friendly fabrics launch ~US$5 million Q1 post-launch 2023 Early commercial traction
Industry Earnings Trend -3.6% Annual Chemicals industry average decline
For additional context on company background, ownership and strategic positioning, see: Zhejiang Hugeleaf Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) - Profitability Metrics

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) shows a mixed profitability profile across recent trailing twelve months (TTM) metrics and year‑specific performance. Key figures highlight solid bottom‑line conversion but limited operating efficiency and uneven asset returns.
  • Net profit margin (TTM): 12.99% - strong conversion of sales into net income.
  • Operating margin (TTM): 1.14% - limited operating efficiency, indicating narrow core profitability.
  • Return on assets (ROA, TTM): -0.35% - negative, signaling challenges in generating returns from asset base.
  • Return on equity (ROE, TTM): 5.12% - below industry average (15%), suggesting weaker shareholder returns over the TTM.
  • Net income (TTM): CN¥196.38 million; Diluted EPS (TTM): CN¥0.06.
  • ROE (2022): 20% - materially above the 15% industry average, indicating strong historical equity returns in 2022.
Metric TTM 2022 Industry Avg
Net Profit Margin 12.99% - -
Operating Margin 1.14% - -
ROA -0.35% - -
ROE 5.12% 20.00% 15.00%
Net Income CN¥196.38M - -
Diluted EPS CN¥0.06 - -
  • Implication: The high net profit margin with low operating margin suggests non‑operating items or one‑time gains supported net income in the TTM period.
  • Implication: The swing from ROE of 20% in 2022 to 5.12% (TTM) points to significant year‑over‑year variability in profitability or capital structure changes.
  • Implication: Negative ROA indicates the company is not effectively leveraging assets to produce net income over the TTM.
Exploring Zhejiang Hugeleaf Co.,Ltd. Investor Profile: Who's Buying and Why?

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) - Debt vs. Equity Structure

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) presents a capital structure characterized by low-to-moderate leverage in recent reporting periods, supported by a strong cash position and a conservative historical stance on debt.
  • Debt-to-equity ratio (MRQ): 21.31
  • Total debt (MRQ): CN¥631.11 million
  • Total cash (MRQ): CN¥779.33 million
  • Book value per share (MRQ): CN¥1.17
  • Debt-to-equity ratio (2022): 0.5
  • Net debt (FY2025): CN¥0 (debt-free)
The interplay between debt and cash results in a net cash position for the most recent fiscal year, while the MRQ debt-to-equity ratio of 21.31 (interpreted here as 0.2131 in conventional ratio terms) signals a moderate reliance on borrowed funds relative to equity. The historical 2022 ratio of 0.5 reflects a more conservative leverage posture, and the reported net debt of zero for FY2025 confirms the company reached a debt-free standing by that fiscal year. Capital allocation priorities are focused on technology and capacity expansion, which affects long-term asset and equity growth:
  • CapEx allocation: 60% technological upgrades, 30% production capacity expansion, 10% other initiatives
Metric Value Period
Debt-to-Equity Ratio 21.31 MRQ
Total Debt CN¥631.11 million MRQ
Total Cash CN¥779.33 million MRQ
Net Debt CN¥0 FY2025
Book Value Per Share CN¥1.17 MRQ
Debt-to-Equity Ratio 0.5 2022
CapEx Allocation 60% Tech / 30% Capacity / 10% Other Ongoing
For further context on strategic direction and capital deployment, see: Mission Statement, Vision, & Core Values (2026) of Zhejiang Hugeleaf Co.,Ltd.

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) - Liquidity and Solvency

  • Current ratio (FY 2023): 2.99 - reported as a 42.17% year-over-year decrease.
  • Current ratio (FY 2022): 2.5 - noted as above the industry average of 1.8.
  • Quick ratio (excludes inventory): not specified in reports; critical for short-term liquidity assessment and should be derived or requested.
  • Operating cash flow (TTM): CN¥ -61.86 million, indicating negative cash flow from operations over the trailing twelve months.
  • Solvency ratio: 2.254, reflecting ability to meet long-term obligations.
  • ERP implementation: integrated supply chain management, reduced lead times, and improved inventory management.
Metric Value (2023) Value (2022) Industry Benchmark / Notes
Current Ratio 2.99 2.5 Industry avg: 1.8
Quick Ratio Not specified Not specified Exclude inventory for stricter liquidity check
Operating Cash Flow (TTM) CN¥ -61.86M - Negative OCF signals operational cash pressure
Solvency Ratio 2.254 - Higher than 1 implies coverage of long-term liabilities
ERP / Inventory Management Implemented - Improved lead times and inventory control
  • Implications for investors:
    • A 2023 current ratio of 2.99 suggests adequate short-term liquidity on paper, but the reported YoY decrease merits investigation into working capital shifts.
    • Negative operating cash flow (CN¥ -61.86M TTM) is a red flag for operational cash generation despite positive current ratio figures.
    • Quick ratio absence means inventory may materially support current assets; verify inventory composition and turnover to assess liquidity realism.
    • Solvency ratio of 2.254 indicates coverage of long-term obligations, but capital structure and debt maturities should be reviewed.
    • ERP-driven supply chain improvements can reduce working capital needs and support future liquidity - monitor realized benefits in cash flow and inventory days.
Zhejiang Hugeleaf Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) - Valuation Analysis

Zhejiang Hugeleaf's current market multiples point to a premium valuation relative to peers and historical norms. Key headline figures (as of July 1, 2025) show elevated earnings- and cash-flow-based ratios alongside modest book- and sales-based metrics, implying investor expectations for growth or scarcity value despite recent price volatility.
  • Trailing P/E: 46.00 - high relative to typical industrial/consumer cyclicals.
  • Price-to-Sales (TTM): CN¥5.43 - market is paying CN¥5.43 per CN¥1 of sales.
  • Price-to-Book (MRQ): CN¥2.35 - market values net assets at ~2.35x book.
  • Enterprise Value / Revenue: 5.47 - enterprise-level revenue multiple is elevated.
  • Enterprise Value / EBITDA: 127.56 - extremely high, signaling very low reported EBITDA or lofty EV.
  • Market Capitalization: CN¥8.21 billion (as of July 1, 2025).
  • 52-week range: CN¥1.82 - CN¥3.03, demonstrating notable price swings.
Metric Value Notes
Trailing P/E 46.00 Implied high earnings multiple
Price-to-Sales (TTM) 5.43 Market paying >5x revenue
Price-to-Book (MRQ) 2.35 Net assets valued >2x
EV / Revenue 5.47 Enterprise-level revenue multiple
EV / EBITDA 127.56 Very high - could reflect low EBITDA or inflated EV
Market Cap CN¥8.21 billion As of 2025-07-01
52-Week Low / High CN¥1.82 / CN¥3.03 Demonstrates recent volatility
Assessing these multiples alongside operational and cash-flow metrics is essential to judge whether the high P/E and extreme EV/EBITDA are justified by growth prospects, one-time accounting items, or depressed EBITDA. For further context on corporate goals and strategic positioning that may underpin valuation, see Mission Statement, Vision, & Core Values (2026) of Zhejiang Hugeleaf Co.,Ltd.

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) Risk Factors

Zhejiang Hugeleaf Co.,Ltd. faces a set of measurable financial risks that investors should weigh carefully. Key red flags include compressed profitability, weakening liquidity trends, reliance on debt financing, negative cash generation, and valuation concerns relative to earnings.
  • Profitability pressure: Gross margin is 8.5% vs. industry average of 23.8%, limiting operating leverage and buffer against cost shocks.
  • Cash-flow weakness: Trailing twelve months (TTM) operating cash flow is CN¥-61.86 million, indicating the core business is not generating positive operating cash.
  • Valuation risk: Trailing P/E of 46.00 may reflect high expectations and increases downside if earnings disappoint.
  • Debt exposure: Debt-to-equity ratio of 21.31 suggests material use of debt financing that can amplify stress in revenue downturns or rising rates.
  • Declining short-term liquidity: Current ratio fell to 2.99 from 5.18 in 2022, signaling reduced cushion for near-term obligations.
  • Technical/sentiment warning: Stock issued a sell signal from the 3-month MACD on October 10, 2025, indicating negative momentum among traders.
Metric Value Comparison / Note
Gross Margin 8.5% Industry avg: 23.8%
Operating Cash Flow (TTM) CN¥-61.86M Negative cash generation
Trailing P/E 46.00 Elevated vs. typical market/peers
Debt-to-Equity Ratio 21.31 Significant leverage reliance
Current Ratio 2.99 Down from 5.18 in 2022
3-month MACD Signal Sell (as of 2025-10-10) Technical negative momentum
  • Operational implications: Low gross margin constrains the company's ability to absorb raw material cost increases or to fund margin expansion investments without eroding profitability further.
  • Liquidity and financing: Despite a current ratio above 1, the sharp decline from 5.18 to 2.99 suggests working capital has tightened; combined with negative operating cash flow, the company may need external financing to support operations or capex.
  • Market and investor risk: High P/E coupled with negative cash flows and weakening liquidity increases execution risk-disappointing results could trigger re-rating and share price pressure.
Mission Statement, Vision, & Core Values (2026) of Zhejiang Hugeleaf Co.,Ltd.

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) - Growth Opportunities

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) is positioning itself for scalable expansion through product innovation, technology investment and faster time-to-market. Recent product launches and R&D activities have translated into measurable top-line gains and efficiency improvements that investors should track.
  • New product traction: The 2023 eco-friendly fabrics line generated approximately $5.0 million in revenue in its first quarter, signaling strong market acceptance for sustainable offerings.
  • Biodegradable tea bags: Launch contributed to a 25% increase in product sales in the past fiscal year, boosting category mix toward higher-margin, environmentally conscious SKUs.
  • Innovation pipeline: The firm filed 5 new patents in 2022, reflecting an active product development agenda and IP build-out to protect differentiated products.
Operational and R&D investments underpin these growth vectors:
  • R&D spend: $3.0 million invested in 2022 to support materials science, process improvements and new product formulations.
  • Product development speed: A 6-month product development cycle enables rapid market entry and seasonal responsiveness.
  • Technology-led efficiency: Investments in automation and digital tools are projected to drive a ~10% annual increase in operational efficiency, reducing unit costs and shortening lead times.
Metric Value / Year
Q1 2023 Eco-friendly fabrics revenue $5,000,000
Patents filed 5 (2022)
R&D investment $3,000,000 (2022)
Product development cycle 6 months
Sales lift from biodegradable tea bags +25% (past fiscal year)
Projected operational efficiency growth ~10% annual
Key investor implications and near-term catalysts:
  • Revenue diversification: New sustainable product lines reduce reliance on legacy products and open premium pricing opportunities.
  • Margin expansion potential: Efficiency gains from technology and higher-margin biodegradable products can widen gross margins over 12-24 months.
  • IP-driven defensibility: The 5 patents strengthen barriers to entry for competitors and support licensing or partnerships.
  • Speed to market: A 6-month cycle supports quicker monetization of trends and seasonal windows, enhancing revenue predictability.
For a deeper look at ownership, recent trading and investor activity around Zhejiang Hugeleaf Co.,Ltd., see: Exploring Zhejiang Hugeleaf Co.,Ltd. Investor Profile: Who's Buying and Why?

DCF model

Zhejiang Hugeleaf Co.,Ltd. (600226.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.